Home/Filings/4/0001209191-23-021136
4//SEC Filing

KENNEY CHRISTOPHER JOHN 4

Accession 0001209191-23-021136

CIK 0001582313other

Filed

Mar 23, 8:00 PM ET

Accepted

Mar 24, 7:18 PM ET

Size

4.5 KB

Accession

0001209191-23-021136

Insider Transaction Report

Form 4
Period: 2023-03-24
KENNEY CHRISTOPHER JOHN
Chief Medical Officer
Transactions
  • Sale

    Common Shares

    2023-03-24$35.01/sh700$24,5070 total

Issuer

Xenon Pharmaceuticals Inc.

CIK 0001582313

Entity typeother

Related Parties

1
  • filerCIK 0001880129

Filing Metadata

Form type
4
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 7:18 PM ET
Size
4.5 KB